A Phase 1 Study of VG-3927 in Healthy Adults and Patients With Alzheimer's Disease

Clinical trial NCT06343636 · COMPLETED

Trial details

NCT number: NCT06343636
Sponsor: Vigil Neuroscience, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Alzheimer Disease

Start date: 2023-09-22
Primary completion: 2025-01-10
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.